Indefinite Delivery Contract 75R60220D00004

Award Date 6/9/20
Last Date to Order 9/26/24
Federal Agency
Headquarters
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract awarded by the Health Resources and Services Administration (HRSA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at up to $50,000,000, was awarded to Telligen, Inc. to provide evaluation studies and related services to various HRSA bureaus and offices over a period of 5 years through September 2024. The contracted services include evaluation studies, information...
This is a single-award Indefinite Delivery Contract (IDC) valued at $350,000,000 awarded by the Health Resources and Services Administration (HRSA), a civilian federal agency, to Policy And Research L.L.C., a woman-owned small business research and evaluation firm based in New Orleans, Louisiana. The contract is for evaluation studies and evidence-building activities across four task areas: 1) program evaluations, 2) other evidence-building activities like needs assessments and predictive...
The Federal Contract IDV award is for an Indefinite Delivery Contract (IDC) titled "EVALUATIONS AND EVIDENCE BUILDING IDIQ" with a ceiling value of $350,000,000 over a period of 5 years. The contract was awarded by the Health Resources and Services Administration (HRSA), a civilian federal agency, to Mathematica Inc., a woman-owned business. The purpose of this IDC is to provide HRSA with a contract mechanism to facilitate the production of relevant, high-priority, and robust...
This indefinite delivery contract was awarded by the Health Resources and Services Administration (HRSA), a civilian federal agency, to L&M Policy Research, LLC, a minority-owned and women-owned small disadvantaged business. The $50 million multiple-award contract has a period of performance of one base year and four one-year option periods, with a ceiling value of $50 million. The contract aims to procure a range of evaluation services and related deliverables to support HRSA's bureaus...
The federal contract IDV award is a $5 million Indefinite Delivery Contract (IDC) with the Centers for Disease Control and Prevention (CDC) for high-impact program evaluation projects. The prime contractor is Tanaq Support Services, LLC, an Alaskan Native Corporation-owned small business that provides specialized professional and technical services to federal agencies, particularly the CDC. Under this IDC, Tanaq Support Services has been awarded several firm-fixed price delivery orders for...
This indefinite delivery contract (IDC) was awarded by the Health Resources and Services Administration (HRSA), a civilian agency within the U.S. Department of Health and Human Services, to Child Trends, Incorporated, a nonprofit research organization. The $50 million IDC, known as the HRSA Evaluation Studies 2019 contract, provides a mechanism for HRSA to procure a range of evaluation services, including studies, syntheses, policy assessments, performance measurement tools, and evaluation...
The federal contract IDV award is an Indefinite Delivery Contract with a ceiling value of $10,000,000 issued by the Food and Drug Administration (FDA) to the Lovelace Biomedical Research Institute, a non-profit contract research organization. The contract aims to procure preclinical research services and support the development of treatments and cures for various diseases and conditions, including respiratory diseases, HIV/AIDS, pain disorders, COVID-19 medical countermeasures, infectious...
This Indefinite Delivery Contract (IDC) was awarded by the Health Resources and Services Administration (HRSA), a civilian agency, to the prime contractor L&M Policy Research, LLC, a minority-owned, woman-owned, and economically disadvantaged small business. The $350 million, single-award IDC has a period of performance from September 2024 to September 2025, with four one-year option periods. The IDC is intended to provide HRSA with a contract mechanism to facilitate the production of...
This indefinite delivery contract (IDC) was awarded by the Health Resources and Services Administration (HRSA), a civilian federal agency, to the National Opinion Research Center (NORC), a non-profit research organization. The contract, with a ceiling value of $350 million, has a period of performance from September 2024 to September 2025 with four one-year option periods. The purpose of this single-award IDC is to provide HRSA with a mechanism to obtain evidence-building and evaluation...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR), to Bryce Space and Technology, LLC (doing business as Brycetech, LLC), a woman-owned small business. The BPA, with a total ceiling value of $77.8 million, is to provide a range of professional services to support ASPR's Health and Human Services...
  • 75R60220D00004
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The federal contract IDV is a $50 million Indefinite Delivery Contract awarded by the Department of Health and Human Services Health Resources and Services Administration (HRSA) to Policy And Research L.L.C. (doing business as Policy & Research Group), a woman-owned small business research and evaluation company. The contract is for the provision of evaluation studies, with a period of performance through September 2024.

Under this IDV contract, HRSA issued a $2,984,376 firm fixed price delivery order to Policy & Research Group to assess the impacts of the COVID-19 pandemic on evidence-based home visiting programs. This delivery order, which has a period of performance through September 2025, is part of HRSA's broader efforts to understand how home visiting programs have adapted their practices in response to the public health emergency. Policy & Research Group has prior experience supporting HRSA and other HHS agencies with research, analysis, and evaluation related to home visiting programs and the COVID-19 pandemic's effects on service delivery.

Generated 1/8/25, 9:03 AM